Disease Info Card

Pallidoluysian Degeneration

Information about Pallidoluysian Degeneration: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Pallidoluysian Degeneration

Most recent studies have shown that Pallidoluysian Degeneration shares some biological mechanisms with ataxia, ataxia-spinocerebellar, atrophy, cerebellar-ataxia, chorea, dementia, dentatorubral-pallidoluysian-atrophy, epilepsies-myoclonic, epilepsy, huntington-disease, machado-joseph-disease, muscular-atrophy, myoclonic-epilepsies-progressive, myoclonus, nerve-degeneration, nervous-system-disorder, neurodegenerative-disorders, spinal-and-bulbar-muscular-atrophy-x-linked-1, spinocerebellar-degeneration, trinucleotide-repeat-expansion.

Among the many pathways, these few ones have gauged particular interests from scientists studying Pallidoluysian Degeneration, and have been seen in publications frequently: Angiogenesis, Cell Death, Embryo Development, Localization, Neuroprotection, Nuclear Export, Pathogenesis, Spermatogenesis, Transport

Quite a number of genes have been found to play important roles in Pallidoluysian Degeneration, such as AR, ATN1, ATXN1, ATXN2, ATXN3, ATXN7, BAIAP2, CACNA1A, CASP3, HTT, ITPR1, JPH3, LY6E, MAGI1, PDYN, PRNP, SLC6A4, TBP. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.